Bharat Immunologicals EBITDA

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

EBITDA Analysis

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Bharat Immunologicals 
EBITDA 
 = 
Revenue 
-  
Basic Expenses 
 = 
37.37 M

About EBITDA

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Compare to competition
According to company disclosure Bharat Immunologicals Biologicals Corp Ltd reported earnings before interest,tax, depreciation and amortization of 37.37 M. This is much higher than that of the Healthcare sector, and significantly higher than that of EBITDA industry, The EBITDA for all stocks is over 1000% lower than the firm.

Peer Comparison

Bharat Immunologicals EBITDA Comparison
Bharat Immunologicals is currently under evaluation in ebitda category among related companies.

Did you try this?

Run Correlation Analysis Now
   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Correlation Analysis

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Fundamental Indicators

Current Bharat Immunologicals financial ratios